S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Ocugen Stock Price, News & Analysis (NASDAQ:OCGN)

$2.15
+0.33 (+18.13 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$1.75
Now: $2.15
$2.19
50-Day Range N/A
52-Week Range
$1.22
Now: $2.15
$50.40
Volume3.19 million shs
Average Volume435,435 shs
Market Capitalization$3.40 million
P/E RatioN/A
Dividend YieldN/A
Beta3
Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases. Its pipeline includes OCU400 and OCU410 for the treatment of inherited retinal disorders; OCU200 for the treatment of wet-AMD, DME, and diabetic retinopathy; OCU100 for retinitis pigmentosa; and OCU300, which is in Phase III clinical trial for the treatment of ocular graft versus host diseases. The company based in Malvern, Pennsylvania.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OCGN
CUSIPN/A
CIKN/A
Phone781-547-7900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.44) per share

Profitability

Net Income$-8,640,000.00

Miscellaneous

Employees14
Market Cap$3.40 million
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable

Receive OCGN News and Ratings via Email

Sign-up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter.


Ocugen (NASDAQ:OCGN) Frequently Asked Questions

What is Ocugen's stock symbol?

Ocugen trades on the NASDAQ under the ticker symbol "OCGN."

How were Ocugen's earnings last quarter?

Ocugen (NASDAQ:OCGN) posted its earnings results on Friday, August, 9th. The company reported ($1.80) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by $1.20. View Ocugen's Earnings History.

When is Ocugen's next earnings date?

Ocugen is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Ocugen.

Has Ocugen been receiving favorable news coverage?

Press coverage about OCGN stock has trended negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ocugen earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Ocugen.

Who are some of Ocugen's key competitors?

What other stocks do shareholders of Ocugen own?

Who are Ocugen's key executives?

Ocugen's management team includes the folowing people:
  • Dr. Shankar Musunuri Ph.D., MBA, Founder, Chairman & CEO
  • Dr. Uday B. Kompella, Founder & Director
  • Dr. Rasappa Arumugham, Chief Scientific Officer
  • Ms. Kelly A. Beck M.B.A., P.M.P., SPHR, VP of Investor Relations & Admin.
  • Dr. Daniel M. Jorgensen M.D., MPH, MBA, Chief Medical Officer

How do I buy shares of Ocugen?

Shares of OCGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ocugen's stock price today?

One share of OCGN stock can currently be purchased for approximately $2.15.

How big of a company is Ocugen?

Ocugen has a market capitalization of $3.40 million. The company earns $-8,640,000.00 in net income (profit) each year or ($47.31) on an earnings per share basis. Ocugen employs 14 workers across the globe.View Additional Information About Ocugen.

What is Ocugen's official website?

The official website for Ocugen is http://www.histogenics.com/.

How can I contact Ocugen?

Ocugen's mailing address is 830 WINTER STREET 3RD FLOOR, WALTHAM MA, 02451. The company can be reached via phone at 781-547-7900 or via email at [email protected]


MarketBeat Community Rating for Ocugen (NASDAQ OCGN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about Ocugen and other stocks. Vote "Outperform" if you believe OCGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What are Bollinger Bands?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel